Adma Biologics (ADMA) Treasury Shares (2025 - 2026)

Adma Biologics (ADMA) has 1 years of Treasury Shares data on file, last reported at $32.1 million in Q4 2025.

• Quarterly Treasury Shares changed N/A year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $5.1 million, down 10.47% from the prior year.
• Treasury Shares eased to $1.9 million in Q4 2025, from $5.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $12.5 million in Q4 2023 to a low of $686133.0 in Q2 2021.
• A 5-year average of $5.0 million and a median of $4.8 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2021 — Treasury Shares soared 1275.81% — and 2022, when it plunged 36.08%.
• Tracing ADMA's Treasury Shares over 5 years: stood at $4.5 million in 2021, then sank by 36.08% to $2.9 million in 2022, then surged by 336.1% to $12.5 million in 2023, then sank by 52.24% to $6.0 million in 2024, then plunged by 67.86% to $1.9 million in 2025.
• The last three Treasury Shares figures came in at $32.1 million (Q4 2025), $8.0 million (Q3 2025), and $15.1 million (Q2 2025), per Business Quant data.